Insilico Medicine Initiates AI Driven Collaboration with Leading Global Cancer Center to Identify Novel Targets for Gastroesophageal Cancers (IMAGE)

InSilico Medicine

Insilico Medicine Initiates AI Driven Collaboration with Leading Global Cancer Center to Identify Novel Targets for Gastroesophageal Cancers

Caption

The collaboration is currently centered on data gathering, quality control, and integration. Subsequent phases anticipate involving AI driven hypothesis generation, target ranking, and detailed biological investigation. The project also supports the evaluation and advancement of identified targets across a range of therapeutic modalities, including biologics and small molecules.

Credit

Insilico Medicine

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.